“At Stago, we are dedicated to providing advanced solutions for hemostasis and thrombosis analysis. Our innovative analyzer and reagent systems are trusted by clinical and research laboratories worldwide. Contact us to learn more”
Officer details are public data from the Companies House register.
People and entities with significant control, from the Companies House PSC register
Balance sheet as at 31 December 2025 · small accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £621,798 | £757,258 | £754,731 | £810,923 | £1,020,820 | £1,023,026 |
| Current Assets | £5,701,941 | £5,266,973 | £4,678,233 | £4,161,726 | £3,455,507 | £2,769,002 |
| Debtors | £2,136,222 | £2,275,504 | £2,213,594 | £2,142,485 | £1,653,814 | £923,172 |
| Cash | £2,725,146 | £2,017,875 | £1,697,642 | £1,254,241 | £918,502 | £706,093 |
| Creditors (< 1 year) | £1,190,966 | £1,241,030 | £1,139,731 | £1,102,758 | £1,017,971 | £2,682,185 |
| Creditors (> 1 year) | £0 | £3,596,000 | ||||
| Net Current Assets | £4,510,975 | £4,025,943 | £3,538,502 | £3,058,968 | £2,437,536 | £86,817 |
| Net Assets | £5,062,873 | £4,698,201 | £4,231,733 | £3,822,291 | £3,458,356 | (£2,486,157) |
| Shareholder Funds | £5,062,873 | £4,698,201 | £4,231,733 | £3,822,291 | £3,458,356 | (£2,486,157) |
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 28 August 2026 | Confirmation statement with no updates | 17 January 2026 | ||
| 16 July 2026 | Cessation of a person with significant control | |||
| 16 July 2026 | Notification of a person with significant control statement | |||
| 2 June 2026 | Termination of appointment of a secretary | |||
| 1 June 2026 | Accounts for a small company | 31 December 2025 |
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →